🟢 GT Biopharma is trading 7.68% up in after-hours trading after Nasdaq disclosed a 1-for-25 reverse split

GT Biopharma is trading 7.68% up at $0.26 after Nasdaq disclosed a 1-for-25 reverse stock split.

• Effective September 8, 2026, the split will consolidate every 25 shares into one and introduce CUSIP 36254L407.
• Split-adjusted trading begins at market open.
• Shares fell 4.52% during the September 4 regular session before reversing higher after hours.